Picture1.jpg
Nuwellis, Inc. To Announce First Quarter 2022 Financial Results on May 10, 2022
12. April 2022 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, April 12, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its first quarter 2022 financial results will be released on Tuesday, May 10, 2022. The company...
Picture1.jpg
Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study
15. März 2022 07:00 ET | Nuwellis, Inc.
MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the...
Picture1.jpg
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results
01. März 2022 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, March 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the fourth quarter and full year ended December 31, 2021, which included the following...
Picture1.jpg
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
22. Februar 2022 17:15 ET | Nuwellis, Inc.
MINNEAPOLIS, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective February 22, 2022, the independent directors approved equity awards under Nuwellis’ 2021...
Picture1.jpg
Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload
17. Februar 2022 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will evaluate the clinical outcomes and economic value of its Aquadex® therapy in comparison...
Picture1.jpg
Nuwellis, Inc. to Announce Fourth Quarter 2021 Financial Results on March 1, 2022
01. Februar 2022 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its fourth quarter 2022 financial results will be released on Tuesday, March 1, 2022. The company...
Picture1.jpg
New Category III CPT Code for the Nuwellis Aquadex Ultrafiltration System is Now in Effect
25. Januar 2022 08:00 ET | Nuwellis, Inc.
EDEN PRAIRIE, Minn., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that the new and dedicated Category III Current Procedural Terminology (CPT®) code, 0692T for...
Picture1.jpg
Nuwellis, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
19. November 2021 16:00 ET | Nuwellis, Inc.
MINNEAPOLIS, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective November 17, 2021, the independent directors approved an equity award under Nuwellis’...
Picture1.jpg
Nuwellis, Inc. Announces Third Quarter 2021 Financial Results
09. November 2021 08:00 ET | Nuwellis, Inc.
MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the third quarter ended September 30, 2021, which included the following highlights: ...
Picture1.jpg
Aquadex SmartFlow® System by Nuwellis Selected as a 2021 R&D 100 Awards Winner
04. November 2021 08:00 ET | Nuwellis, Inc.
EDEN PRAIRIE, Minn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) was honored at the 2021 R&D 100 Awards last month, with its Aquadex SmartFlow® system selected as a winner in...